ConductScience.org, home
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
API referenceFor AI assistants

Trial · NCT01120028

Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Period 1: Alemtuzumab or BasiliximabSTARTEDPeriod 1: Alemtuzumab/Tacrolimus426
Period 1: Alemtuzumab or BasiliximabSTARTEDPeriod 1: Basiliximab/Tacrolimus426
Period 1: Alemtuzumab or BasiliximabSTARTEDPeriod 2: Sirolimus0
Period 1: Alemtuzumab or BasiliximabSTARTEDPeriod 2: Tacrolimus0
Period 1: Alemtuzumab or BasiliximabCOMPLETEDPeriod 1: Alemtuzumab/Tacrolimus412
Period 1: Alemtuzumab or BasiliximabCOMPLETEDPeriod 1: Basiliximab/Tacrolimus403
Period 1: Alemtuzumab or BasiliximabCOMPLETEDPeriod 2: Sirolimus0
Period 1: Alemtuzumab or BasiliximabCOMPLETEDPeriod 2: Tacrolimus0
Period 1: Alemtuzumab or BasiliximabNOT COMPLETEDPeriod 1: Alemtuzumab/Tacrolimus14
Period 1: Alemtuzumab or BasiliximabNOT COMPLETEDPeriod 1: Basiliximab/Tacrolimus23
Period 1: Alemtuzumab or BasiliximabNOT COMPLETEDPeriod 2: Sirolimus0
Period 1: Alemtuzumab or BasiliximabNOT COMPLETEDPeriod 2: Tacrolimus0
Period 2: Tacrolimus or SirolimusSTARTEDPeriod 1: Alemtuzumab/Tacrolimus0
Period 2: Tacrolimus or SirolimusSTARTEDPeriod 1: Basiliximab/Tacrolimus0
Period 2: Tacrolimus or SirolimusSTARTEDPeriod 2: Sirolimus197
Period 2: Tacrolimus or SirolimusSTARTEDPeriod 2: Tacrolimus197
Period 2: Tacrolimus or SirolimusCOMPLETEDPeriod 1: Alemtuzumab/Tacrolimus0
Period 2: Tacrolimus or SirolimusCOMPLETEDPeriod 1: Basiliximab/Tacrolimus0
Period 2: Tacrolimus or SirolimusCOMPLETEDPeriod 2: Sirolimus197
Period 2: Tacrolimus or SirolimusCOMPLETEDPeriod 2: Tacrolimus197

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01120028/flow

API referenceFor AI assistants